Skip to main content

Month: July 2021

New governance for McPhy

Laurent Carme is stepping down as CEOLuc Poyer, Chairman of the Board of Directors, will also act temporarily as CEO La Motte-Fanjas, July 12, 2021 (7.00 am CEST) – McPhy Board of Directors terminated Laurent Carme’s role as CEO. A selection process for a new CEO has been initiated. Luc Poyer, Chairman of the Board of Directors, will act temporarily as CEO. The priority of the Chairman and CEO and of the Board of Directors will be to lead an efficient transition, in close collaboration with the management team, to make sure that current operations and projects are carried out properly, and to ensure that the company’s customers and partners remain satisfied. The hydrogen sector is growing, supported by a European investment program of more than 7 billion euros in France and 9 billion euros in Germany between now and 2030. McPhy is very...

Continue reading

Penn Virginia Announces Agreement to Acquire Lonestar Resources 

Continues Accretive Eagle Ford Consolidation Complementary Assets, Increased Scale, Free Cash Flow and Inventory HOUSTON, July 12, 2021 (GLOBE NEWSWIRE) — Penn Virginia Corporation (“Penn Virginia” or the “Company”) (NASDAQ: PVAC) and Lonestar Resources US Inc. (“Lonestar”) (OTCQX: LONE) today announced that they have entered into a definitive merger agreement under which Penn Virginia will acquire Lonestar in an all-stock transaction. Under the terms of the agreement, Lonestar shareholders will receive 0.51 shares of common stock of Penn Virginia for each share of common stock of Lonestar outstanding. The transaction, which is expected to close in the second half of 2021, has been unanimously approved by the boards of directors of both companies. The closing of the transaction is subject to customary closing...

Continue reading

ToughBuilt Industries, Inc. Announces $40 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Lake Forest, Calif, July 11, 2021 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt” or the “Company”) (NASDAQ: TBLT; TBLTW), today announced that it has entered into securities purchase agreements with certain institutional investors for the issuance and sale of 46,029,920 shares of common stock and warrants to purchase up to 23,014,960 shares of common stock, at a purchase price of $0.869 per share and accompanying warrant in a registered direct offering priced at-the-market under Nasdaq rules. The warrants will be immediately exercisable at an exercise price of $0.81 per share of common stock and will expire five years from the date of issuance. The closing of the offering is expected to occur on or about July 14, 2021, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting...

Continue reading

CurrencyWorks Announces $3.75 Million Registered Direct Offering

Los Angeles, CA, July 11, 2021 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a blockchain pioneer, NFT, and digital payment provider, today announced that it has entered into securities purchase agreements with institutional investors for the purchase of 4,687,500 shares of common stock and warrants to purchase 4,687,500 shares of common stock in a registered direct offering. The purchase price for one share of common stock and one warrant to purchase one share of common stock is $0.80. The warrants have an exercise price of $1.00 per share, will be immediately exercisable and expire five years from the issue date. The offering is expected to close on or about July 14, 2021, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting...

Continue reading

Kyahn Williamson Joins Telix to Lead Corporate Communications and Investor Relations

MELBOURNE, Australia, July 11, 2021 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) is pleased to announce that Ms. Kyahn Williamson has joined the Telix executive leadership team in the role of Senior Vice President of Corporate Communications and Investor Relations. Kyahn joins Telix from WE Communications, where she was Group Head of Investor and Corporate Communication. Over the past 15 years, Kyahn has worked with a wide range of ASX-listed companies spanning the medtech and biotech sectors, designing and implementing investor relations and public relations strategies, and advising across multiple IPOs and M&A transactions. Ms. Williamson stated, “I’m absolutely delighted to join the team and apply my deep industry experience to support Telix as it makes the transition to a commercial...

Continue reading

Maha Energy AB (publ) (“Maha” or the “Company”) announces spud of Tie-4 and an operational update

Maha Energy AB spudded its first horizontal well with a planned Electric Submersible Pump (“ESP”) artificial lift system on the Tie field late on 9 July, 2021. This marks the implementation of two new technologies the Company is applying to the productive Tie field in Brazil.  Since May this year the Company has already drilled 5 oil wells in Illinois Basin (“IB”) and is drilling 7 additional oil wells. All wells will be stimulated using high pressure stimulation and, all going well, the 12 oil well work program is scheduled to be completed by the end of September. Tie-3 was recently acid stimulated and is back online and is showing good improvement in production. Second quarter (“Q2”) production numbers were lower than planned for the quarter due to planned and unplanned shutdowns at the Tie field production facility. At this time,...

Continue reading

InterCure provides an Update on its NASDAQ Listing

Trading on the world’s leading stock exchange expected to begin in the last week of July TORONTO and HERZLIYA, Israel, July 10, 2021 (GLOBE NEWSWIRE) — InterCure Ltd. (TSX: INCR.U, TASE: INCR)(dba Canndoc)(the “Company”) is pleased to announce that further to its confidential filing with the U.S. Securities and Exchange Commission (the “SEC“) of its 20F registration statement on April 20, 2021, it will publicly file its 20F registration statement the week of July 11. The Company has also applied to list its common shares (the “Common Shares“) on the NASDAQ Capital Market (“NASDAQ“) under the trading symbol “INCR”, pending the public filing of the 20F registration statement and the satisfaction of certain other conditions. The Company expects that the Common Shares will commence...

Continue reading

Exploration Successes Point to Longer Life for Tongon

All amounts expressed in US dollars. TONGON GOLD MINE, Côte d’Ivoire, July 10, 2021 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD) (TSX:ABX) – Significant exploration successes could extend the Tongon gold mine’s life, Barrick president and chief executive Mark Bristow said today. Speaking at a local media briefing, Bristow said 10 years after it went into production Tongon could get a new lease on life thanks to promising results from near-mine exploration campaigns designed to replace the mine’s depleted reserves. In addition to work on the promising Seydou North and Tongon West targets, Tongon has filed the documentation for the extension of its Nielle mining licence by a further 10 years, to support the drive to add to its life-of-mine. Bristow said Barrick, through its predecessor Randgold Resources, had been investing...

Continue reading

AWILCO DRILLING PLC (AWDR) – Notification of primary insider trade

On 8 July 2021, funds managed by QVT Financial LP (“QVT”) purchased in the open market 20,386 shares in Awilco Drilling Plc (“Awilco Drilling”) at a price of NOK 3.3 per share. Following the aforementioned transactions, funds managed or otherwise deemed controlled by QVT hereafter own a total of 4,881,167 shares in Awilco Drilling, or 8.94% of the registered share capital. QVT’s CEO and founder, Dan Gold, is a member of the board of directors of Awilco Drilling PLC. For further information, please contact Meg Eisner at QVT Financial LP at +1 (212) 705-6229.This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentKRT 1500 8 July 2021 AWDR NO

Continue reading

BioCryst Reports 96-week Data from APeX-2 Showing ORLADEYO®(berotralstat) Reduced HAE Attack Rate by 80 Percent from Baseline

—Multiple data presentations at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress 2021 highlight durability of effect and long-term safety of ORLADEYO— RESEARCH TRIANGLE PARK, N.C., July 10, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that hereditary angioedema (HAE) patients who were randomized to receive 150 mg of oral, once-daily ORLADEYO® (berotralstat) at the start of the APeX-2 trial had an 80 percent average reduction in their mean attack rate per month during weeks 25-96 of the trial, compared to baseline. Median attack rates also decreased from 2.7 attacks/month at baseline to 0.0 attacks per month in 16 of 17 months through the same period. ORLADEYO was generally well-tolerated during the treatment period with fewer drug-related adverse events reported...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.